282 related articles for article (PubMed ID: 9694539)
1. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis.
Holvoet P; Collen D
Atherosclerosis; 1998 Apr; 137 Suppl():S33-8. PubMed ID: 9694539
[TBL] [Abstract][Full Text] [Related]
2. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
3. Oxidized lipoproteins in atherosclerosis and thrombosis.
Holvoet P; Collen D
FASEB J; 1994 Dec; 8(15):1279-84. PubMed ID: 8001740
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein and atherosclerosis.
Devaraj S; Jialal I
Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
[TBL] [Abstract][Full Text] [Related]
5. The role of oxidized lipoproteins in atherogenesis.
Berliner JA; Heinecke JW
Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation.
Wen Y; Killalea S; Norris LA; Cooke T; Feely J
Eur J Clin Invest; 1999 Dec; 29(12):1027-34. PubMed ID: 10583450
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of lipoproteins and atherosclerosis.
Luc G; Fruchart JC
Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
[TBL] [Abstract][Full Text] [Related]
8. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis.
Ylä-Herttuala S
Ann Med; 1991; 23(5):561-7. PubMed ID: 1721825
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidized low density lipoprotein in atherogenesis.
Jialal I; Devaraj S
J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
Frei B
Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
[TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
Napoli C
G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
[TBL] [Abstract][Full Text] [Related]
12. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM
Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
[TBL] [Abstract][Full Text] [Related]
13. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
Fuller CJ; Grundy SM; Norkus EP; Jialal I
Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
[TBL] [Abstract][Full Text] [Related]
14. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
[TBL] [Abstract][Full Text] [Related]
15. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
Aviram M
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
[TBL] [Abstract][Full Text] [Related]
16. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
[TBL] [Abstract][Full Text] [Related]
17. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
Staprans I; Pan XM; Rapp JH; Feingold KR
Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
[TBL] [Abstract][Full Text] [Related]
18. Complement activation by oxidatively modified low-density lipoproteins.
Wieland E; Dorweiler B; Bonitz U; Lieser S; Walev I; Bhakdi S
Eur J Clin Invest; 1999 Oct; 29(10):835-41. PubMed ID: 10583425
[TBL] [Abstract][Full Text] [Related]
19. [Determination of malondialdehyde-modified LDL(MDA-LDL) and its potential usefulness].
Kotani K; Kondo A; Manabe M; Maekawa M; Kanno T
Rinsho Byori; 1997 Jan; 45(1):47-54. PubMed ID: 9022342
[TBL] [Abstract][Full Text] [Related]
20. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
Moriel P; Okawabata FS; Abdalla DS
IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
